Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AVArx vs Layla

AVArx
Graded #427

Lower grade

vs+15.000000000000007
Layla
Graded #103

Higher grade

The verdict

Layla takes it — 70.9/100 to 55.9/100.

Layla grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLayla +21
45
66
Dose & formulationLayla +56
40
96
Clinical oversightAVArx +1
77
76
Labs & monitoringEven
52
52
FulfillmentAVArx +20
85
65
Contract termsLayla +14
41
55
AVArx · left barLayla · right bar

The numbers

MetricAVArxLayla
WeighScore55.9/10070.9/100
GradeCC
Scorecard rank#427#103
SemaglutideNot disclosed$237/mo (all doses, compounded)
TirzepatideNot disclosed$199/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
AVArx

Graded #427 · C

Strengths

  • Publishes exactly which states require a live audio or video visit before a prescription, which almost no competitor discloses
  • Names its prescribing group, Arora Health & Aesthetics, and gives a medical compliance contact
  • Terms state service is available to residents of all 50 states, and the shipping policy matches
  • Dates its own editorial reviews on treatment pages
  • HSA/FSA accepted with receipts provided for reimbursement

Where it loses points

  • No price is published anywhere on the site, on treatment pages or in the intake, so you cannot compare before starting a visit
  • Never states whether its semaglutide and tirzepatide are compounded or brand-name
  • No dispensing pharmacy is named, only licensed pharmacies in our network
  • Cancellation terms are not published, only presented at checkout
  • Prescriptions cannot be returned once dispensed, and the refund policy is otherwise unstated
Layla

Graded #103 · C

Strengths

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where it loses points

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard